Healthcare Chatbots Market Size, Share, and Growth Analysis, By Component (Software, Services), By Deployment Model (On-premise Model, Cloud-based Model), By Application, By End User, By Region - Industry Forecast 2025-2032
헬스케어 챗봇 세계 시장 규모는 2023년 3억 2,522만 달러로 평가되었습니다. 또한, 2024년 3억 9,319만 달러에서 2032년에는 17억 9,479만 달러로 성장하고, 예측 기간(2025-2032년) 동안 20.9%의 연평균 복합 성장률(CAGR)을 보일 것으로 예측됩니다.
헬스케어 분야에서는 AI 기반 챗봇에 대한 수요가 급증하고 있으며, 지불자가 잠재 고객과 소통하는 방식에 혁명을 일으키고 있습니다. 이러한 디지털 어시스턴트는 문의에 효율적으로 대응하고, 임상 팀이 관리 부담에서 벗어나 핵심 업무에 집중할 수 있도록 돕습니다. 업무 자동화 기술에 대한 의존도가 높아짐에 따라 챗봇은 환자 참여 강화, 건강 정보 제공, 원격 의료 이니셔티브 지원에 필수적인 역할을 하고 있습니다. 특히, 이러한 도구는 1차 진료 의사의 업무량을 줄이는 동시에 개인이 자신의 건강을 스스로 관리할 수 있도록 장려하기 위해 만들어졌습니다. 놀랍게도, 불우한 배경을 가진 환자의 약 40%가 치료를 완료하지 못하고 있습니다. 뉴욕의 대형 의료 서비스 제공업체인 노스웰 헬스(Northwell Health)와 같이 이 문제를 해결하는 것이 그 어느 때보다 중요해졌습니다.
목차
서론
조사 방법
- 정보 조달
- 2차와 1차 데이터 방법
- 시장 규모 예측
- 시장 전제조건과 제한
주요 요약
- 세계 시장 전망
- 공급과 수요 동향 분석
- 부문별 기회 분석
시장 역학과 전망
- 시장 개요
- 시장 규모
- 시장 역학
- Porter의 Five Forces 분석
주요 시장 인사이트
- 중요 성공 요인
- 경쟁 정도
- 주요 투자 기회
- 시장 생태계
- 시장의 매력 지수(2024년)
- PESTEL 분석
- 거시경제 지표
- 밸류체인 분석
- 가격 분석
- 기술 진보
- 특허 분석
헬스케어 챗봇 시장 규모 : 구성요소별
헬스케어 챗봇 시장 규모 : 도입 모델별
- 시장 개요
- 온프레미스 모델
- 클라우드 기반 모델
헬스케어 챗봇 시장 규모 : 용도별
- 시장 개요
- 증상 확인 및 투약 지원
- 예약 스케줄 및 의료 가이던스
헬스케어 챗봇 시장 규모 : 최종사용자별
- 시장 개요
- 환자
- 의료 제공자
- 보험 회사
- 기타 최종사용자
헬스케어 챗봇 시장 규모
- 북미
- 유럽
- 아시아태평양
- 라틴아메리카
- 중동 및 아프리카
- GCC 국가
- 남아프리카공화국
- 기타 중동 및 아프리카
경쟁 정보
- 주요 5개사 비교
- 주요 기업의 시장 포지셔닝(2024년)
- 주요 시장 기업이 채택한 전략
- 최근 시장 동향
- 기업의 시장 점유율 분석(2024년)
- 주요 기업 개요
- 기업 상세
- 제품 포트폴리오 분석
- 기업 부문별 점유율 분석
- 매출 전년대비 비교(2022-2024년)
주요 기업 개요
- Babylon Health(United Kingdom)
- HealthTap Inc.(United States)
- Ada Health GmbH(Germany)
- Infermedica(Poland)
- MD Limited(United Kingdom)
- Woebot Labs, Inc.(United States)
- GYANT(United States)
- Sensely, Inc.(United States)
- Baidu Inc.(China)
- Buoy Health, Inc.(United States)
- HealthJoy(United States)
- Your.MD(United Kingdom)
- Lifelink Systems(United States)
- Panda Health(United States)
- GYANT.Com Inc.(United States)
- Ada Digital Health Ltd.(United Kingdom)
- Babylon Healthcare Service Limited(United Kingdom)
- Buoy Health Inc.(United States)
- GYANT.Com Inc.(United States)
- Infermedica Sp. z o.o.(Poland)
결론과 제안
LSH
Global Healthcare Chatbots Market size was valued at USD 325.22 million in 2023 and is poised to grow from USD 393.19 million in 2024 to USD 1794.79 million by 2032, growing at a CAGR of 20.9% during the forecast period (2025-2032).
The healthcare sector is witnessing a burgeoning demand for AI-driven chatbots, which are revolutionizing the way payers engage with potential clients. These digital assistants efficiently address inquiries, relieving clinical teams from administrative burdens and enabling them to focus on core responsibilities. With increasing reliance on technology to automate operations, chatbots have become essential for enhancing patient engagement, disseminating health information, and supporting telemedicine initiatives. Notably, these tools have been created to alleviate the workload for primary care physicians while encouraging individuals to take charge of their health. Alarmingly, around 40% of patients from underprivileged backgrounds do not complete treatment; addressing this issue has never been more vital, epitomized by entities like Northwell Health, a leading healthcare provider in New York.
Top-down and bottom-up approaches were used to estimate and validate the size of the Global Healthcare Chatbots market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Global Healthcare Chatbots Market Segments Analysis
Global Healthcare Chatbots Market is segmented by Component, Deployment Model, Application, End User and region. Based on Component, the market is segmented into Software and Services. Based on Deployment Model, the market is segmented into On-premise Model and Cloud-based Model. Based on Application, the market is segmented into Symptom Checking & Medication Assistance and Appointment Scheduling & Medical Guidance. Based on End User, the market is segmented into Patients, Healthcare Providers, Insurance Companies and Other End Users. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Driver of the Global Healthcare Chatbots Market
The expansion of the global healthcare chatbots market is primarily fueled by the rising demand for remote patient monitoring and telehealth solutions. This trend is rooted in a patient-centric and technology-driven evolution within the healthcare sector. Additionally, the global surge in chronic diseases, coupled with an aging population, has heightened the need for ongoing health condition management and monitoring beyond conventional in-person healthcare methods. As patients seek more convenient and efficient ways to engage with healthcare services, the adoption of chatbots becomes increasingly vital in addressing these evolving healthcare demands.
Restraints in the Global Healthcare Chatbots Market
The global healthcare chatbots market faces several significant restraints, primarily revolving around data security concerns. While data is crucial for enhancing the personalized experience of patients, it also makes these chatbots vulnerable to various threats, including malware attacks, distributed denial-of-service (DDoS) attacks, and risks stemming from inadequate coding practices and security measures. Despite advancements in technology, apprehensions regarding data privacy continue to create skepticism among consumers, ultimately impeding the widespread adoption of chatbots within the healthcare sector. Consequently, such issues are contributing to a slowdown in the growth of the global healthcare chatbots market.
Market Trends of the Global Healthcare Chatbots Market
The global healthcare chatbots market is witnessing significant growth driven by the integration of digital technology in healthcare. As more healthcare providers transition to online services, the demand for efficient patient engagement tools is rising, positioning chatbots as key assets in enhancing customer interactions and operational efficiency. These AI-driven solutions offer a user-friendly interface, enabling patients to access health information and receive personalized recommendations easily. This technological advancement not only improves patient experiences but also streamlines healthcare operations, creating a favorable environment for the expansion of the chatbot market as healthcare systems increasingly seek innovative ways to meet evolving patient needs.
Table of Contents
Introduction
- Objectives of the Study
- Scope of the Report
- Definitions
Research Methodology
- Information Procurement
- Secondary & Primary Data Methods
- Market Size Estimation
- Market Assumptions & Limitations
Executive Summary
- Global Market Outlook
- Supply & Demand Trend Analysis
- Segmental Opportunity Analysis
Market Dynamics & Outlook
- Market Overview
- Market Size
- Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
- Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers
Key Market Insights
- Key Success Factors
- Degree of Competition
- Top Investment Pockets
- Market Ecosystem
- Market Attractiveness Index, 2024
- PESTEL Analysis
- Macro-Economic Indicators
- Value Chain Analysis
- Pricing Analysis
- Technological Advancement
- Patent Analysis
Global Healthcare Chatbots Market Size by Component & CAGR (2025-2032)
- Market Overview
- Software
- Services
Global Healthcare Chatbots Market Size by Deployment Model & CAGR (2025-2032)
- Market Overview
- On-premise Model
- Cloud-based Model
Global Healthcare Chatbots Market Size by Application & CAGR (2025-2032)
- Market Overview
- Symptom Checking & Medication Assistance
- Appointment Scheduling & Medical Guidance
Global Healthcare Chatbots Market Size by End User & CAGR (2025-2032)
- Market Overview
- Patients
- Healthcare Providers
- Insurance Companies
- Other End Users
Global Healthcare Chatbots Market Size & CAGR (2025-2032)
- North America (Component, Deployment Model, Application, End User)
- Europe (Component, Deployment Model, Application, End User)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
- Asia Pacific (Component, Deployment Model, Application, End User)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
- Latin America (Component, Deployment Model, Application, End User)
- Brazil
- Rest of Latin America
- Middle East & Africa (Component, Deployment Model, Application, End User)
- GCC Countries
- South Africa
- Rest of Middle East & Africa
Competitive Intelligence
- Top 5 Player Comparison
- Market Positioning of Key Players, 2024
- Strategies Adopted by Key Market Players
- Recent Developments in the Market
- Company Market Share Analysis, 2024
- Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2022-2024)
Key Company Profiles
- Babylon Health (United Kingdom)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- HealthTap Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Ada Health GmbH (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Infermedica (Poland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- MD Limited (United Kingdom)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Woebot Labs, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- GYANT (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Sensely, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Baidu Inc. (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Buoy Health, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- HealthJoy (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Your.MD (United Kingdom)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Lifelink Systems (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Panda Health (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- GYANT.Com Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Ada Digital Health Ltd. (United Kingdom)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Babylon Healthcare Service Limited (United Kingdom)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Buoy Health Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- GYANT.Com Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Infermedica Sp. z o.o. (Poland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Conclusion & Recommendations
